Clinical Trials Directory

Trials / Unknown

UnknownNCT01177865

Study of Treatment Choice in Patients With Localized Prostate Cancer

Evaluating Patient Preferences for the Treatment of Localized Prostate Cancer - A Discrete Choice Experiment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
432 (estimated)
Sponsor
University College London Hospitals · Academic / Other
Sex
Male
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Gathering information about patients with prostate cancer may help doctors learn more about how patients choose treatment options. PURPOSE: This study is looking at treatment choice in patients with localized prostate cancer.

Detailed description

OBJECTIVES: Primary * To evaluate the importance of prostate cancer treatment characteristics to men with localized prostate cancer. * To determine to what extent men will choose the strengths and weaknesses of one treatment over a different set of strengths and weaknesses of another treatment when making a choice between them. Secondary * To determine the correlation between attributes that are important to men and baseline demographics, functional status, and disease risk characteristics. OUTLINE: This is a multicenter study. Patients complete a 'discrete choice experiment' questionnaire presenting three treatment options based on 8 aspects of treatment. Attributes relevant to men with prostate cancer (e.g., sexual health, urinary function, return to normal activities \[work, gardening, sports, shopping\]) that apply to surveillance, radical therapies and new minimally-invasive therapies have been selected for consideration. Baseline demographics such as age, working/retired/unemployed/household income, prostate cancer characteristics (PSA level, Gleason grade, stage), baseline functional status (genitourinary function), and final treatment choice will also be collected in order to ascertain whether there is any relationship and association between patient preferences for treatment and these baseline demographics. Individuals will be asked to choose between the three treatment profiles.

Conditions

Interventions

TypeNameDescription
OTHERinformational intervention
OTHERquestionnaire administration

Timeline

Start date
2010-09-01
Primary completion
2012-09-01
First posted
2010-08-09
Last updated
2013-08-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01177865. Inclusion in this directory is not an endorsement.